159 related articles for article (PubMed ID: 21524681)
1. Biomarker-based dissection of neurodegenerative diseases.
Olsson B; Zetterberg H; Hampel H; Blennow K
Prog Neurobiol; 2011 Dec; 95(4):520-34. PubMed ID: 21524681
[TBL] [Abstract][Full Text] [Related]
2. The role of genetics for biomarker development in neurodegeneration.
Bertram L; Hampel H
Prog Neurobiol; 2011 Dec; 95(4):501-4. PubMed ID: 22005514
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects.
Cedazo-Minguez A; Winblad B
Exp Gerontol; 2010 Jan; 45(1):5-14. PubMed ID: 19796673
[TBL] [Abstract][Full Text] [Related]
4. Development of biomarkers for multiple sclerosis as a neurodegenerative disorder.
Ziemann U; Wahl M; Hattingen E; Tumani H
Prog Neurobiol; 2011 Dec; 95(4):670-85. PubMed ID: 21524682
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases.
Tumani H; Teunissen C; Süssmuth S; Otto M; Ludolph AC; Brettschneider J
Expert Rev Mol Diagn; 2008 Jul; 8(4):479-94. PubMed ID: 18598229
[TBL] [Abstract][Full Text] [Related]
6. Clinical proteomics in neurodegenerative disorders.
Zetterberg H; Rüetschi U; Portelius E; Brinkmalm G; Andreasson U; Blennow K; Brinkmalm A
Acta Neurol Scand; 2008 Jul; 118(1):1-11. PubMed ID: 18279484
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers in clinical trials for neurodegenerative diseases: regulatory perspectives and requirements.
Broich K; Weiergräber M; Hampel H
Prog Neurobiol; 2011 Dec; 95(4):498-500. PubMed ID: 21945642
[TBL] [Abstract][Full Text] [Related]
8. Oxysterols as biomarkers in neurodegenerative diseases.
Leoni V; Caccia C
Chem Phys Lipids; 2011 Sep; 164(6):515-24. PubMed ID: 21515244
[TBL] [Abstract][Full Text] [Related]
9. [CSF biomarkers: proteomics investigations and clinical applications in neurodegenerative disorders].
Gabelle A; Roche S; Lehmann S
Rev Neurol (Paris); 2009 Mar; 165(3):213-22. PubMed ID: 18808768
[TBL] [Abstract][Full Text] [Related]
10. Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics.
Kroksveen AC; Opsahl JA; Aye TT; Ulvik RJ; Berven FS
J Proteomics; 2011 Apr; 74(4):371-88. PubMed ID: 21111852
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers of neurodegenerative disorders: how good are they?
Rachakonda V; Pan TH; LE WD
Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
[TBL] [Abstract][Full Text] [Related]
12. Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases.
Otto M; Lewczuk P; Wiltfang J
Methods; 2008 Apr; 44(4):289-98. PubMed ID: 18374272
[TBL] [Abstract][Full Text] [Related]
13. High-field magnetic resonance imaging of brain iron: birth of a biomarker?
Schenck JF; Zimmerman EA
NMR Biomed; 2004 Nov; 17(7):433-45. PubMed ID: 15523705
[TBL] [Abstract][Full Text] [Related]
14. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
Barchet TM; Amiji MM
Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid biomarkers in neurological diseases in children.
Shahim P; Månsson JE; Darin N; Zetterberg H; Mattsson N
Eur J Paediatr Neurol; 2013 Jan; 17(1):7-13. PubMed ID: 23026858
[TBL] [Abstract][Full Text] [Related]
16. Ethical considerations of biomarker use in neurodegenerative diseases--a case study of Alzheimer's disease.
Prvulovic D; Hampel H
Prog Neurobiol; 2011 Dec; 95(4):517-9. PubMed ID: 22137044
[TBL] [Abstract][Full Text] [Related]
17. Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases.
Steinacker P; Mollenhauer B; Bibl M; Cepek L; Esselmann H; Brechlin P; Lewczuk P; Poser S; Kretzschmar HA; Wiltfang J; Trenkwalder C; Otto M
Neurosci Lett; 2004 Nov; 370(1):36-9. PubMed ID: 15489013
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers in aquatic plants: selection and utility.
Brain RA; Cedergreen N
Rev Environ Contam Toxicol; 2009; 198():49-109. PubMed ID: 19253039
[TBL] [Abstract][Full Text] [Related]
19. Progranulin: normal function and role in neurodegeneration.
Eriksen JL; Mackenzie IR
J Neurochem; 2008 Jan; 104(2):287-97. PubMed ID: 17953663
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular characteristics in Marfan syndrome and their relation to the genotype.
De Backer J
Verh K Acad Geneeskd Belg; 2009; 71(6):335-71. PubMed ID: 20232788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
